Priorix Tetra
Active ingredient not listed in the SAHPRA register
Glaxosmithkline South Africa (Pty) Limited
Registration
- Applicant
- Glaxosmithkline South Africa (Pty) Limited
- Certificate holder
- Glaxosmithkline South Africa (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Priorix tetra EACH 0,5 ml DOSE CONTAINS MEASLES VIRUS ( LIVE ATTENUATED ) not less than 10 (3.0) CCID 50MUMPS VIRUS ( LIVE ATTENUATED ) not less than 10 (4.4) CCID 50RUBELLA VIRUS (LIVE ATTENUATED ) not less than 10 (3.0) CCID 50 VARICEL | 0,5 mlPowder and diluent for solution for injection | 43012743/30.1/0127Approved 13 March 2018 | Registered | Not determined | PIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
The SAHPRA register lists no active ingredient for this product, so there is no compound to show.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.